Summary:
- The article explores the dual-use risks and benefits of utilizing generative AI models to engineer novel viral proteins and synthetic viruses for potential therapeutic applications.
- It highlights the ongoing debate within the scientific community regarding the need for robust regulatory frameworks and biosafety guardrails to prevent the misuse of AI-driven biotechnology.